Andrew Roddam

Andrew Roddam is a seasoned leader in the life sciences sector, currently serving as the Chief Strategy Officer at EveryONE Medicines and as an Advisory Board Member at Axia Medicine. As the founder of Cibola Life Sciences Ltd, Andrew offers consultancy services focused on go-to-market and growth strategies for organizations intersecting data/digital and biology. Andrew holds a management board position at SNOMED International, where contributions include chairing the Technical Innovation Committee. Previous roles include Chief Executive Officer at Our Future Health UK and Vice President positions at GSK and Amgen, where Andrew emphasized data strategy and epidemiological research. Andrew's academic background includes a DPhil in Statistics from the University of Oxford and a BSc (Hons) in Mathematics & Statistics from the University of Warwick.